Can I stack BPC-157 with TB-500?
Yes — the BPC-157 and TB-500 stack is the most-reported recovery combination. They work through complementary mechanisms and pair cleanly.
Updated May 7, 2026 · 3 min read
Yes — the BPC-157 + TB-500 stack is the most-reported peptide recovery combination, and the two compounds work through complementary mechanisms that pair cleanly. The case for stacking is strongest for stubborn or chronic injuries; for acute, well-localized issues, BPC-157 alone is usually sufficient.
The mechanism case
The reason these two pair well is that they don't overlap:
| Property | BPC-157 | TB-500 |
|---|---|---|
| Primary action | Local angiogenesis + growth factors | Systemic actin reorganization + cell migration |
| Best route | SubQ near injury | SubQ systemic |
| Half-life | Hours | Days |
| Cadence | Daily | Twice weekly loading, then every 1–2 weeks |
| Best for | Targeted local repair | Whole-body recovery, hard-to-localize injuries |
BPC-157 builds blood vessels and recruits growth factors at a specific site. TB-500 reorganizes the cytoskeleton and signals stem-cell migration across the body. Both contribute to repair through separate pathways.
When the stack is worth the cost
Stacking adds vials, money, and injection logistics. The stack earns it for:
- Chronic tendinopathy that hasn't moved on 4 weeks of BPC-157 alone
- Multiple overlapping injuries (rotator-cuff + lower back + Achilles, for example)
- Athletes managing accumulated systemic damage from a hard training cycle
- Post-surgical recovery (if cleared by your surgeon) where you want broad and local support
When the stack is overkill:
- Recent acute strain — BPC-157 alone usually does the job
- A specific gut / GI focus — BPC-157 is the targeted tool
- First-time peptide use — start with one to establish your baseline
The standard stacked protocol
| Compound | Dose | Cadence |
|---|---|---|
| BPC-157 | 250 mcg | Daily SubQ near affected tissue |
| TB-500 | 2.5–5 mg | Twice weekly SubQ (loading), then every 1–2 weeks |
Total cycle: 6–8 weeks. Reassess at the end. Most users discontinue both rather than running maintenance indefinitely.
Injection logistics
You don't mix the two in the same syringe. Standard pattern:
- BPC-157: morning SubQ, near the injury site
- TB-500: morning SubQ on the dosing day (typically Monday and Thursday for twice-weekly loading), in a different SubQ site
Using different sites makes dose tracking cleaner and reduces local irritation.
Side-effect overlap
The stack doesn't double the side-effect risk, but it doesn't halve it either:
- Lethargy in the first 1–2 weeks (more pronounced with TB-500 loading)
- Mild headaches
- More injection-site reactions (more sites, more chances)
The shared mechanism caution is the angiogenesis / cell-regeneration profile. Both peptides activate these pathways. The standard caution applies to the stack:
- Active or recent cancer: don't run either
- Family history of cancer: discuss with a clinician
- No cancer history, normal screening: theoretical risk, proceed informed
Cost reality
A typical stacked cycle (8 weeks):
| Item | Quantity | Approximate cost |
|---|---|---|
| BPC-157 (5 mg vials) | 2–3 vials | $80–150 |
| TB-500 (5 mg vials) | 4–6 vials | $200–400 |
| BAC water + syringes | — | $30–50 |
| Total | $310–600 |
Compared to a BPC-157-only cycle ($120–250), the stack is roughly 2–3x the cost. Worth it for stubborn cases. Overkill for routine recovery.
A reasonable decision tree
- Acute, localized injury, recent (under 6 weeks)? → BPC-157 alone for 4–6 weeks.
- Chronic tendinopathy or recurring injury, 6+ weeks unresolved? → BPC-157 alone first, 4 weeks. If only partial improvement, add TB-500 loading.
- Whole-body recovery focus, multiple overlapping issues? → Stack from the start, 6–8 weeks.
- Budget constraint, only one peptide? → BPC-157 (broader use, lower cost, more research).
- Active or recent cancer, family history of malignancy? → Talk to a clinician first.